Bisirna Therapeutics Pte. Ltd.
1 clinical trials · Sponsor
◉ Watch Bisirna Therapeutics Pte. Ltd.
| Record | Firm | Date |
|---|---|---|
| Phase Ib Clinical Study to Evaluate the Safety and Tolerability of VSA012 Injection in Paroxysmal Nocturnal Hemoglobinuria (NCT06848296) | Bisirna Therapeutics Pte. Ltd. | 2025-04-15 |
Track Bisirna Therapeutics Pte. Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.